Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
18.18
-3.06 (-14.41%)
At close: Oct 30, 2026, 4:00 PM EST
18.18
0.00 (0.00%)
Pre-market: Nov 2, 2026, 5:00 AM EST
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.61 billion as of October 30, 2026. It is the 7,493rd most valuable company in the world and the 1,928th biggest in the United States. Its market cap has decreased by 48.38% in one year.
Market Cap
1.61B
Enterprise Value
1.04B
1-Year Change
-48.38%
Global Rank
Country Rank
#1,928 United States
Category
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.61B, an increase of 157.20%. That is a compound annual growth rate of 28.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.61B | -44.04% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.67B |
| Replimune Group | 1.67B |
| Kailera Therapeutics | 1.67B |
| Novavax | 1.66B |
| UroGen Pharma | 1.60B |
| Nanobiotix | 1.60B |
| Ultragenyx Pharmaceutical | 1.58B |
| Immunocore Holdings | 1.57B |